Supriya Lifescience
Supriya Lifescience Performance
Day Range
- Low 281.10
- High 294.35
52 Week Range
- Low 170.15
- High 310.60
- Open Price291.40
- Previous Close291.30
- Volume504519
Start SIP in Supriya Lifescience
Start SIPSupriya Lifescience Investment Rating
-
Master Rating:
-
Supriya Lifescience has an operating revenue of Rs. 519.53 Cr. on a trailing 12-month basis. An annual revenue de-growth of -12% needs improvement, Pre-tax margin of 27% is great, ROE of 12% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 8% and 15% from 50DMA and 200DMA. It is currently FORMING a base in its weekly chart and is trading around 9% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 86 which is a GOOD score indicating consistency in earnings, a RS Rating of 43 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 149 indicates it belongs to a poor industry group of Medical-Supplies and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
Indicator | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
---|---|---|---|---|---|---|---|
Oper Rev Qtr Cr | 140 | 132 | 142 | 105 | 112 | 101 | 181 |
Operating Expenses Qtr Cr | 108 | 88 | 87 | 91 | 61 | 70 | 106 |
Operating Profit Qtr Cr | 32 | 44 | 55 | 14 | 52 | 31 | 75 |
Depreciation Qtr Cr | 4 | 4 | 3 | 3 | 3 | 3 | 3 |
Interest Qtr Cr | 0 | 1 | 1 | 1 | 24 | 1 | 1 |
Tax Qtr Cr | 6 | 14 | 15 | 3 | 11 | 5 | 29 |
Net Profit Qtr Cr | 24 | 29 | 38 | 10 | 17 | 25 | 46 |
Supriya Lifescience Technicals
EMA & SMA

- Bullish Moving Average
- ___
- 15
- Bearish Moving Average
- ___
- 1
- 20 Day
- ₹263.46
- 50 Day
- ₹260.88
- 100 Day
- ₹259.06
- 200 Day
- ₹261.50
- 20 Day
- ₹258.47
- 50 Day
- ₹259.93
- 100 Day
- ₹263.31
- 200 Day
- ₹243.47
Supriya Lifescience Resistance and Support
Resistance | |
---|---|
First Resistance | 290.77 |
Second Resistance | 299.18 |
Third Resistance | 304.02 |
RSI | 64.15 |
MFI | 83.36 |
MACD Single Line | 2.13 |
MACD | 7.02 |
Support | |
---|---|
First Resistance | 277.52 |
Second Resistance | 272.68 |
Third Resistance | 264.27 |
Supriya Lifescience Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 542,582 | 27,975,528 | 51.56 |
Week | 1,042,689 | 40,258,203 | 38.61 |
1 Month | 582,567 | 23,063,835 | 39.59 |
6 Month | 374,110 | 15,682,707 | 41.92 |
Supriya Lifescience Result Highlights
Supriya Lifescience Synopsis
NSE-Medical-Supplies
Supriya Lifescience is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 460.94 Cr. and Equity Capital is Rs. 16.10 Cr. for the Year ended 31/03/2023. Supriya Lifescience Ltd. is a Public Limited Listed company incorporated on 26/03/2008 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L51900MH2008PLC180452 and registration number is 180452.Market Cap | 2,272 |
Sales | 520 |
Shares in Float | 2.58 |
No of funds | 22 |
Yield | 0.21 |
Book Value | 3.25 |
U/D Vol ratio | 0.9 |
LTDebt / Equity | |
Alpha | 0.05 |
Beta | 1.01 |
Supriya Lifescience
Owner Name | Sep-23 | Jun-23 | Mar-23 | Dec-22 |
---|---|---|---|---|
Promoters | 68.3% | 68.3% | 68.28% | 68.24% |
Mutual Funds | 1.74% | 2.14% | 2.38% | 2.38% |
Insurance Companies | 3.89% | 3.86% | 3.73% | 3.85% |
Foreign Portfolio Investors | 5.35% | 5.73% | 5.66% | 6.24% |
Individual Investors | 16.1% | 15.4% | 15.55% | 15.07% |
Others | 4.62% | 4.57% | 4.4% | 4.22% |
Supriya Lifescience Management
Name | Designation |
---|---|
Mr. Satish Waman Wagh | Chairman & Managing Director |
Ms. Smita Satish Wagh | Whole Time Director |
Ms. Saloni Satish Wagh | Whole Time Director |
Ms. Shivani Satish Wagh | Whole Time Director |
Mr. Balasahab Gulabrao Sawant | Whole Time Director |
Mr. Kedar Shankar Karmarkar | Independent Director |
Mr. Bhairav Manojbhai Chokshi | Independent Director |
Mr. Dileep Kumar Jain | Independent Director |
Mr. Dinesh Navnitlal Modi | Independent Director |
Ms. Neelam Yashpal Arora | Independent Director |
Supriya Lifescience Forecast
Price Estimates
Supriya Lifescience Corporate Action
Date | Purpose | Remarks |
---|---|---|
2023-11-07 | Quarterly Results | |
2023-08-03 | Quarterly Results | |
2023-05-26 | Audited Results & Final Dividend | |
2023-02-14 | Quarterly Results | |
2022-11-10 | Quarterly Results |
Supriya Lifescience FAQs
What is Share Price of Supriya Lifescience ?
Supriya Lifescience share price is ₹282 As on 02 December, 2023 | 20:56
What is the Market Cap of Supriya Lifescience ?
The Market Cap of Supriya Lifescience is ₹2272.4 Cr As on 02 December, 2023 | 20:56
What is the P/E ratio of Supriya Lifescience ?
The P/E ratio of Supriya Lifescience is 22.7 As on 02 December, 2023 | 20:56
What is the PB ratio of Supriya Lifescience ?
The PB ratio of Supriya Lifescience is 3.2 As on 02 December, 2023 | 20:56